OasisLMS

This session explores the rapidly evolving global landscape of sports electrophysiology, with a focus on arrhythmias in athletes and the role of exercise in cardiovascular health. Experts from around the world will examine the benefits of physical activity—including its positive effects on atrial fibrillation and overall wellness—while also addressing key issues in physiological monitoring, sports safety for individuals with cardiovascular disease, and the nuanced treatment of arrhythmias in competitive and recreational athletes. The session will also highlight global efforts in sudden cardiac arrest (SCA) prevention, with insights that extend beyond athletes to broader populations across all ages.

• Exchange knowledge between members of the Global EP community and HRS.
• Identify opportunities to improve patient care through a global lens.
• Discover similarities and occasions for collaboration between regional societies.

Christina Miyake, MD, MPH, MS
Adrian Elliott, PhD
Eduardo Saad, MD, PhD
Prashanthan Sanders, MBBS, PhD

ECG Screening in 2026 and Beyond: Our AI Future is Here and Now... (PRO)
Presenter(s): Michael John. Ackerman, MD, PhD

ECG Screening in 2026 and Beyond: Our AI Future is Here and Now... (CON)
Presenter(s): Aneil Malhotra, MA, MBChB, MSci, PhD

Utility of Genetic Testing in the Sports Cardiology Clinic and After Aborted Sudden Death
Presenter(s): Belinda R. Gray, MBBS, PhD

Return to Play in CPVT, Really?
Presenter(s): Susan P. Etheridge, MD

Sports-based Device Programming
Presenter(s): Eugene H. Chung, MD, MPH, MSci

Clinical Utility of Device (Loop) Activity Levels to Guide Management
Presenter(s): Hariharan Raju

Arrhythmogenic Cardiomyopathy: A Gene-specific Exercise Prescription for RTP
Presenter(s): Cynthia A. James, PhD, CGC

Michael Ackerman:

• Solid Bioscience (Intellectual Property Rights - Co-development of joint project)
• Abbott (Honoraria/Speaking/Consulting Fee - Consulting)
• ARMGO Pharma (Honoraria/Speaking/Consulting Fee - Consulting)
• BioMarin, Inc (Honoraria/Speaking/Consulting Fee - Consulting)
• AliveCor (Intellectual Property Rights - Consulting)
• Anumana (Intellectual Property Rights - Consulting)
• Boston Scientific (Honoraria/Speaking/Consulting Fee - Consulting)
• Bristol-Myers Squibb (Honoraria/Speaking/Consulting Fee - Consulting)
• Illumina (Honoraria/Speaking/Consulting Fee - Consulting)
• Medtronic (Honoraria/Speaking/Consulting Fee - Consulting)
• Pfizer, Inc. (Intellectual Property Rights - co-development of joint project)
• Prolaio (Honoraria/Speaking/Consulting Fee - Consulting)
• Tenaya Therapeutics (Honoraria/Speaking/Consulting Fee - Consulting)
• Thryv Therapeutics (Royalty Income - Consulting)
• UpToDate, Inc. (Honoraria/Speaking/Consulting Fee - Consulting)

Aneil Malhotra:

• Nothing Relevant to Disclose

Belinda Gray:

• Bristol-Myers Squibb (Honoraria/Speaking/Consulting Fee - Membership on Advisory Committees or Review Panels)

Susan Etheridge:

• UpToDate, Inc. (Honoraria/Speaking/Consulting Fee - Chapter writer)

Eugene Chung:

• Nothing Relevant to Disclose

Hariharan Raju:

• Nothing Relevant to Disclose

Cynthia James:

• StrideBio (Research (Contracted Grants for PIs and Named Investigators only) - Research)
• ARVADA Therapeutics (Research (Contracted Grants for PIs and Named Investigators only) - Research)
• Lexeo, Inc. (Research (Contracted Grants for PIs and Named Investigators only) - Research)
• Rocket Pharma (Research (Contracted Grants for PIs and Named Investigators only) - Research)
• Tenaya Therapeutics (Research (Contracted Grants for PIs and Named Investigators only) - Research)

To view all Heart Rhythm 2026 Faculty Disclosures, please click here.

Diagnostic Testing
   --   Monitoring and Other Noninvasive Diagnostic Testing
      --   24. Know the indications for exercise stress testing, with or without imaging, in the evaluation and risk stratification of patients with cardiac arrhythmias including ventricular pre-excitation, long QT syndrome (LQTS), catecholaminergic ventricular tachycardia (CPVT) and hypertrophic cardiomyopathy, or who are taking class 1C antiarrhythmic medications.